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Positron emission tomography findings in
systemic juvenile idiopathic arthritis
18F-fluorodeoxyglucose (18FDG) is known to accumulate
in a large spectrum of malignant and non-malignant
pathologies and PET is routinely used to image those
processes [1]. We present here a case of child Still’s
disease with both hypermetabolic polyadenopathies
and hepatosplenomegaly on PET/CT, mimicking a
lymphoma.
A 16-year-old African girl, with a history of diffuse
articular pain, weight loss and night sweating, and show-
ing a back papulomatous rash, hepatosplenomegaly,
diffuse lymph nodes enlargement and symmetrical poly-
arthritis on physical examination, was evaluated on PET/
CT. This exam showed intense accumulation of FDG in
almost all enlarged supra- and infra-diaphragmatic
lymph nodes (maximum standardized uptake value:
4.5–10.7), and in the enlarged liver and spleen, as well
(Fig. 1). A right axillary node biopsy was then performed
and the pathology was consistent with reactive follicular
hyperplasia, with no evidence of lymphoproliferative
disease. On the basis of clinical features, inflammatory
syndrome and hyperferritinaemia, patient was given the
diagnosis of systemic JIA, or Still’s disease. An oral
corticoid treatment was established, to which she
responded well.
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FIG. 1 Hypermetabolic polyadenopathies and hepatos-
plenomegaly on PET/CT.
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